AgingResearch.NewsJoin free

Morphic Medical

CompanyUnited States

Morphic Medical develops one asset, in human trials (RESET in diabetes type2). Mostly device acting on Insulin/IGF-1 signalling; based in the United States.

1
Asset
Furthest stage
Human trials
1
Trial
0
Signals

Pipeline

1

  • RESET

    Endoluminal duodenal bypass liner device for glycemic improvement and weight management

    Human trials, Device, Insulin/IGF-1 signalling, diabetes type2, obesity

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Evidence behind the mechanisms1
  • Trials1
  • Signals1
  • Similar companies6

Papers

Intelligence